Remarkable Response to Crizotinib in Woman With Anaplastic Lymphoma Kinase–Rearranged Anaplastic Thyroid Carcinoma

Godbert et al. (Tue,) studied this question.

www.synapsesocial.com/papers/69d9a7411ad561c673684e35 — DOI: https://doi.org/10.1200/jco.2013.49.6596

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Phase II Trial of Sorafenib in Metastatic Thyroid Cancer· 2009 · 543 citations
2. <i>RET/PTC</i> Rearrangements Preferentially Occurred in Papillary Thyroid Cancer among Atomic Bomb Survivors Exposed to High Radiation Dose· 2008 · 157 citations
3. Treatment of Anaplastic Thyroid Carcinoma with Paclitaxel: Phase 2 Trial Using Ninety-Six-hour Infusion· 2000 · 298 citations
4. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)· 2008 · 29,290 citations
5. Fusion of a Kinase Gene, <i>ALK</i> , to a Nucleolar Protein Gene, <i>NPM</i> , in Non-Hodgkin's Lymphoma· 1994 · 2,401 citations